Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes | NEJM
Original Article from The New England Journal of Medicine — Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
Original Article from The New England Journal of Medicine — Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
Patients with relapsed or refractory hematologic cancers have a poor prognosis. Chimeric antigen receptor (CAR) T-cell therapy as a bridge to allogeneic hematopoietic stem-cell transplantation…
Hearing progressively declines with age, manifesting initially as difficulty understanding speech in background noise and detrimentally affecting social functioning. Strategies and technologies can…
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2023
There is no NHS without the people who work in it, and those people are working incredibly hard to deliver a huge and growing amount…
The police made arrests at Northeastern University, Arizona State and Indiana University on Saturday, as more schools move in on encampments protesting the war in…
The autologous cellular therapy exagamglogene autotemcel is generated by editing an erythroid-specific enhancer of BCL11A. Could another site be edited unintentionally? This study gauged the…
Quick Take Video Summary from The New England Journal of Medicine — FFR-Guided Complete PCI for STEMI
Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered subcut…